Small interfering RNA (siRNA) is a form of genetic medicine that can silence or knock out any overexpressed genes in disease.It's also called short interfering RNA.These rnas are widely used to assess the specific contributions of genes to a variety of cell phenotypes, including apoptosis, pancreatic bird signaling, cytokinesis, and cell differentiation.They are used to identify novel pathways and have a meaningful impact on the identification of targets for several diseases (such as AIDS, cancer and hepatitis) and cellular processes.The mechanism of action of siRNA involves introducing it into cells.SiRNA sequences should be designed to match the short regions of the target gene.Small interfering rnas are processed by the cell's own enzymes to eliminate the mRNA of the target gene, thereby preventing overexpression of the pathogenic gene.It is based on the natural response of cells when they detect genetic abnormalities or infections.It has some advantages over the different types of therapies currently available, such as target specificity, reduced secondary effects, and high specificity.The preclinical development duration of small interfering RNA compounds (about 15 to 24 months) is shorter than that of monoclonal antibodies (about 27 to 50 months) or other traditional small molecules (about 42 to 66 months).The shortening of preclinical stage is attributed to the rational design of RNA.The design includes mathematical algorithms assembled in software to select the most appropriate RNA sequence to silence specific genetic targets.They are usually more effective than other traditional medicines.SiRNA therapy includes liposome-based systemic therapy and nanoparticle based systemic therapy.Liposome-based systems are associated with liver-targeted pharmacokinetics, which limits the therapeutic potential of siRNA therapy to other common liver diseases, such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.
Market Analysis and Insights: Global Small Interfering RNA (siRNA) Therapeutics Market
The global Small Interfering RNA (siRNA) Therapeutics market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Small Interfering RNA (siRNA) Therapeutics Scope and Segment
The global Small Interfering RNA (siRNA) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Interfering RNA (siRNA) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other
By the application, this report covers the following segments
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
Competitive Landscape:
The Small Interfering RNA (siRNA) Therapeutics key manufacturers in this market include:
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis
Market Analysis and Insights: Global Small Interfering RNA (siRNA) Therapeutics Market
The global Small Interfering RNA (siRNA) Therapeutics market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Small Interfering RNA (siRNA) Therapeutics Scope and Segment
The global Small Interfering RNA (siRNA) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Interfering RNA (siRNA) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other
By the application, this report covers the following segments
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
Competitive Landscape:
The Small Interfering RNA (siRNA) Therapeutics key manufacturers in this market include:
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis
1 Market Overview of Small Interfering RNA (siRNA) Therapeutics
1.1 Small Interfering RNA (siRNA) Therapeutics Market Overview
1.1.1 Small Interfering RNA (siRNA) Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2015-2026)
1.4 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 China Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
2 Small Interfering RNA (siRNA) Therapeutics Market Overview by Type
2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Liposome Based Systemic Therapy
2.5 Nanoparticle Based Systemic Therapy
2.6 Other
3 Small Interfering RNA (siRNA) Therapeutics Market Overview by Application
3.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Research Institutions
3.6 Pharmaceutical and Biotechnology Companies
3.7 Academic Institutions
3.8 Other
4 Global Small Interfering RNA (siRNA) Therapeutics Competition Analysis by Players
4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Small Interfering RNA (siRNA) Therapeutics Market
4.4 Global Top Players Small Interfering RNA (siRNA) Therapeutics Headquarters and Area Served
4.5 Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Small Interfering RNA (siRNA) Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 GE
5.1.1 GE Profile
5.1.2 GE Main Business and Company’s Total Revenue
5.1.3 GE Products, Services and Solutions
5.1.4 GE Revenue (US$ Million) (2015-2020)
5.1.5 GE Recent Development and Reaction to Covid-19
5.2 Horizon Discovery
5.2.1 Horizon Discovery Profile
5.2.2 Horizon Discovery Main Business and Company’s Total Revenue
5.2.3 Horizon Discovery Products, Services and Solutions
5.2.4 Horizon Discovery Revenue (US$ Million) (2015-2020)
5.2.5 Horizon Discovery Recent Development and Reaction to Covid-19
5.3 Thermo Scientific
5.5.1 Thermo Scientific Profile
5.3.2 Thermo Scientific Main Business and Company’s Total Revenue
5.3.3 Thermo Scientific Products, Services and Solutions
5.3.4 Thermo Scientific Revenue (US$ Million) (2015-2020)
5.3.5 OPKO Health Recent Development and Reaction to Covid-19
5.4 OPKO Health
5.4.1 OPKO Health Profile
5.4.2 OPKO Health Main Business and Company’s Total Revenue
5.4.3 OPKO Health Products, Services and Solutions
5.4.4 OPKO Health Revenue (US$ Million) (2015-2020)
5.4.5 OPKO Health Recent Development and Reaction to Covid-19
5.5 AInylam Pharmaceuticals
5.5.1 AInylam Pharmaceuticals Profile
5.5.2 AInylam Pharmaceuticals Main Business and Company’s Total Revenue
5.5.3 AInylam Pharmaceuticals Products, Services and Solutions
5.5.4 AInylam Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.5.5 AInylam Pharmaceuticals Recent Development and Reaction to Covid-19
5.6 Arrowhead Research
5.6.1 Arrowhead Research Profile
5.6.2 Arrowhead Research Main Business and Company’s Total Revenue
5.6.3 Arrowhead Research Products, Services and Solutions
5.6.4 Arrowhead Research Revenue (US$ Million) (2015-2020)
5.6.5 Arrowhead Research Recent Development and Reaction to Covid-19
5.7 Sanofi Genzyme
5.7.1 Sanofi Genzyme Profile
5.7.2 Sanofi Genzyme Main Business and Company’s Total Revenue
5.7.3 Sanofi Genzyme Products, Services and Solutions
5.7.4 Sanofi Genzyme Revenue (US$ Million) (2015-2020)
5.7.5 Sanofi Genzyme Recent Development and Reaction to Covid-19
5.8 Genecon Biotechnologies
5.8.1 Genecon Biotechnologies Profile
5.8.2 Genecon Biotechnologies Main Business and Company’s Total Revenue
5.8.3 Genecon Biotechnologies Products, Services and Solutions
5.8.4 Genecon Biotechnologies Revenue (US$ Million) (2015-2020)
5.8.5 Genecon Biotechnologies Recent Development and Reaction to Covid-19
5.9 Arbutus Biopharma
5.9.1 Arbutus Biopharma Profile
5.9.2 Arbutus Biopharma Main Business and Company’s Total Revenue
5.9.3 Arbutus Biopharma Products, Services and Solutions
5.9.4 Arbutus Biopharma Revenue (US$ Million) (2015-2020)
5.9.5 Arbutus Biopharma Recent Development and Reaction to Covid-19
5.10 Silent Therapeutics
5.10.1 Silent Therapeutics Profile
5.10.2 Silent Therapeutics Main Business and Company’s Total Revenue
5.10.3 Silent Therapeutics Products, Services and Solutions
5.10.4 Silent Therapeutics Revenue (US$ Million) (2015-2020)
5.10.5 Silent Therapeutics Recent Development and Reaction to Covid-19
5.11 Sylentis
5.11.1 Sylentis Profile
5.11.2 Sylentis Main Business and Company’s Total Revenue
5.11.3 Sylentis Products, Services and Solutions
5.11.4 Sylentis Revenue (US$ Million) (2015-2020)
5.11.5 Sylentis Recent Development and Reaction to Covid-19
6 North America Small Interfering RNA (siRNA) Therapeutics by Players and by Application
6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
6.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
7 Europe Small Interfering RNA (siRNA) Therapeutics by Players and by Application
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
8 China Small Interfering RNA (siRNA) Therapeutics by Players and by Application
8.1 China Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
8.2 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
9 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics by Players and by Application
9.1 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
10 Latin America Small Interfering RNA (siRNA) Therapeutics by Players and by Application
10.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
10.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
11 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics by Players and by Application
11.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
12 Small Interfering RNA (siRNA) Therapeutics Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 Small Interfering RNA (siRNA) Therapeutics Market Overview
1.1.1 Small Interfering RNA (siRNA) Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2015-2026)
1.4 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 China Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2015-2026)
2 Small Interfering RNA (siRNA) Therapeutics Market Overview by Type
2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Liposome Based Systemic Therapy
2.5 Nanoparticle Based Systemic Therapy
2.6 Other
3 Small Interfering RNA (siRNA) Therapeutics Market Overview by Application
3.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Research Institutions
3.6 Pharmaceutical and Biotechnology Companies
3.7 Academic Institutions
3.8 Other
4 Global Small Interfering RNA (siRNA) Therapeutics Competition Analysis by Players
4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Small Interfering RNA (siRNA) Therapeutics Market
4.4 Global Top Players Small Interfering RNA (siRNA) Therapeutics Headquarters and Area Served
4.5 Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Small Interfering RNA (siRNA) Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 GE
5.1.1 GE Profile
5.1.2 GE Main Business and Company’s Total Revenue
5.1.3 GE Products, Services and Solutions
5.1.4 GE Revenue (US$ Million) (2015-2020)
5.1.5 GE Recent Development and Reaction to Covid-19
5.2 Horizon Discovery
5.2.1 Horizon Discovery Profile
5.2.2 Horizon Discovery Main Business and Company’s Total Revenue
5.2.3 Horizon Discovery Products, Services and Solutions
5.2.4 Horizon Discovery Revenue (US$ Million) (2015-2020)
5.2.5 Horizon Discovery Recent Development and Reaction to Covid-19
5.3 Thermo Scientific
5.5.1 Thermo Scientific Profile
5.3.2 Thermo Scientific Main Business and Company’s Total Revenue
5.3.3 Thermo Scientific Products, Services and Solutions
5.3.4 Thermo Scientific Revenue (US$ Million) (2015-2020)
5.3.5 OPKO Health Recent Development and Reaction to Covid-19
5.4 OPKO Health
5.4.1 OPKO Health Profile
5.4.2 OPKO Health Main Business and Company’s Total Revenue
5.4.3 OPKO Health Products, Services and Solutions
5.4.4 OPKO Health Revenue (US$ Million) (2015-2020)
5.4.5 OPKO Health Recent Development and Reaction to Covid-19
5.5 AInylam Pharmaceuticals
5.5.1 AInylam Pharmaceuticals Profile
5.5.2 AInylam Pharmaceuticals Main Business and Company’s Total Revenue
5.5.3 AInylam Pharmaceuticals Products, Services and Solutions
5.5.4 AInylam Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.5.5 AInylam Pharmaceuticals Recent Development and Reaction to Covid-19
5.6 Arrowhead Research
5.6.1 Arrowhead Research Profile
5.6.2 Arrowhead Research Main Business and Company’s Total Revenue
5.6.3 Arrowhead Research Products, Services and Solutions
5.6.4 Arrowhead Research Revenue (US$ Million) (2015-2020)
5.6.5 Arrowhead Research Recent Development and Reaction to Covid-19
5.7 Sanofi Genzyme
5.7.1 Sanofi Genzyme Profile
5.7.2 Sanofi Genzyme Main Business and Company’s Total Revenue
5.7.3 Sanofi Genzyme Products, Services and Solutions
5.7.4 Sanofi Genzyme Revenue (US$ Million) (2015-2020)
5.7.5 Sanofi Genzyme Recent Development and Reaction to Covid-19
5.8 Genecon Biotechnologies
5.8.1 Genecon Biotechnologies Profile
5.8.2 Genecon Biotechnologies Main Business and Company’s Total Revenue
5.8.3 Genecon Biotechnologies Products, Services and Solutions
5.8.4 Genecon Biotechnologies Revenue (US$ Million) (2015-2020)
5.8.5 Genecon Biotechnologies Recent Development and Reaction to Covid-19
5.9 Arbutus Biopharma
5.9.1 Arbutus Biopharma Profile
5.9.2 Arbutus Biopharma Main Business and Company’s Total Revenue
5.9.3 Arbutus Biopharma Products, Services and Solutions
5.9.4 Arbutus Biopharma Revenue (US$ Million) (2015-2020)
5.9.5 Arbutus Biopharma Recent Development and Reaction to Covid-19
5.10 Silent Therapeutics
5.10.1 Silent Therapeutics Profile
5.10.2 Silent Therapeutics Main Business and Company’s Total Revenue
5.10.3 Silent Therapeutics Products, Services and Solutions
5.10.4 Silent Therapeutics Revenue (US$ Million) (2015-2020)
5.10.5 Silent Therapeutics Recent Development and Reaction to Covid-19
5.11 Sylentis
5.11.1 Sylentis Profile
5.11.2 Sylentis Main Business and Company’s Total Revenue
5.11.3 Sylentis Products, Services and Solutions
5.11.4 Sylentis Revenue (US$ Million) (2015-2020)
5.11.5 Sylentis Recent Development and Reaction to Covid-19
6 North America Small Interfering RNA (siRNA) Therapeutics by Players and by Application
6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
6.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
7 Europe Small Interfering RNA (siRNA) Therapeutics by Players and by Application
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
8 China Small Interfering RNA (siRNA) Therapeutics by Players and by Application
8.1 China Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
8.2 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
9 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics by Players and by Application
9.1 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
10 Latin America Small Interfering RNA (siRNA) Therapeutics by Players and by Application
10.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
10.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
11 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics by Players and by Application
11.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
12 Small Interfering RNA (siRNA) Therapeutics Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
